Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Phase 2, Dose-finding Trial of Once Weekly Petrelintide Compared With Placebo in Participants With Obesity or Overweight With Weight Related Comorbidities

NCT06662539 is registered in ClinicalTrials.gov with Zealand Pharma as lead sponsor.

NCT NCT06662539
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06662539 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Phase 2, Dose-finding Trial of Once Weekly Petrelintide Compared With Placebo in Participants With Obesity or Overweight With Weight Related Comorbidities
Lead sponsor
Zealand Pharma
Phase
Phase 2
Overall status
Completed
Start date
December 9, 2024
Completion date
March 7, 2026
Enrollment
493 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

obesity